Evidence map›Paper›PMID 39333551›Full record

ArticleNature communications2024

Evolutionary origin and population diversity of a cryptic hybrid pathogen.

Jacob L Steenwyk, Sonja Knowles, Rafael W Bastos, Charu Balamurugan, David Rinker, Matthew E Mead, Christopher D Roberts, Huzefa A Raja, Yuanning Li, Ana Cristina Colabardini and 19 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

Jacob L SteenwykHowards Hughes Medical Institute and the Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, USA.
Sonja KnowlesDepartment of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, USA.
Rafael W BastosFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Charu BalamuruganVanderbilt University, Department of Biological Sciences, VU Station B #35-1634, Nashville, USA.ORCID 0009-0006-7746-2248
David RinkerVanderbilt University, Department of Biological Sciences, VU Station B #35-1634, Nashville, USA.ORCID 0000-0001-5894-7633
Matthew E MeadVanderbilt University, Department of Biological Sciences, VU Station B #35-1634, Nashville, USA.
Christopher D RobertsDepartment of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, USA.ORCID 0000-0003-0949-1320
Huzefa A RajaDepartment of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, USA.ORCID 0000-0002-0824-9463
Yuanning LiInstitute of Marine Science and Technology, Shandong University, 72 Binhai Road, Qingdao, China.ORCID 0000-0002-2206-5804
Ana Cristina ColabardiniFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Patrícia Alves de CastroFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Thaila Fernanda Dos ReisFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-7776-977X
Adiyantara GumilangVanderbilt University, Department of Biological Sciences, VU Station B #35-1634, Nashville, USA.
María Almagro-MoltoMax von Pettenkofer-Institut für Hygiene und Medizinische Mikrobiologie, Faculty of Medicine, Ludwig Maximilian University, Munich, Germany.
Alexandre AlanioInstitut Pasteur, Paris Cité University, National Reference Center for Invasives Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, France.
Dea Garcia-HermosoInstitut Pasteur, Paris Cité University, National Reference Center for Invasives Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, France.
Endrews DelbajeFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0002-0313-9046
Laís PontesFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Camila Figueiredo PinzanFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Angélica Zaninelli SchreiberSchool of Medical Sciences, State University of Campinas, Campinas, Brazil.ORCID 0000-0002-5095-5054
David CanóvasDepartamento de Genética, Facultad de Biología, Universidad de Sevilla, Seville, Spain.ORCID 0000-0002-7293-7332
Rafael Sanchez LuperiniFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil.
Katrien LagrouDepartment of Microbiology, Immunology and Transplantation, Katholieke Universiteit Leuven, Leuven, Belgium.
Egídio TorradoLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4715-495 Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.ORCID 0000-0002-7462-8234
Fernando RodriguesLife and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, 4715-495 Braga, Portugal; ICVS/3B's-PT Government Associate Laboratory, Braga, Portugal.
Nicholas H OberliesDepartment of Chemistry & Biochemistry, University of North Carolina at Greensboro, Greensboro, USA.ORCID 0000-0002-0354-8464
Xiaofan ZhouGuangdong Laboratory for Lingnan Modern Agriculture, Guangdong Province Key Laboratory of Microbial Signals and Disease Control, Integrative Microbiology Research Centre, South China Agricultural University, Guangzhou, China.ORCID 0000-0002-2879-6317
Gustavo H GoldmanFaculdade de Ciencias Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, São Paulo, Brazil. ggoldman@usp.br.ORCID 0000-0002-2986-350X
Antonis RokasVanderbilt University, Department of Biological Sciences, VU Station B #35-1634, Nashville, USA. antonis.rokas@vanderbilt.edu.ORCID 0000-0002-7248-6551

Funding

Deciphering the phenotypic and genomic traits that underlie the evolution of pathogenicity differences among Aspergillus fumigatus and its close relativesR01AI153356 · NIAID · VANDERBILT UNIVERSITY · PI Antonis Rokas · 2022 to 2026
$3.5M
Burroughs Wellcome Fund (BWF) N/aHoward Hughes Medical Institute (HHMI) James H. Gilliam Fellowships for Advanced Study programLife Sciences Research Foundation (LSRF) Howard Hughes Medical Institute Awardee of the Life Sciences Research FoundationNational Science Foundation (NSF) DEB-2110404NIAID NIH HHS R01 AI153356
6 · The paper itself

Abstract

Cryptic fungal pathogens pose disease management challenges due to their morphological resemblance to known pathogens. Here, we investigated the genomes and phenotypes of 53 globally distributed isolates of Aspergillus section Nidulantes fungi and found 30 clinical isolates-including four isolated from COVID-19 patients-were A. latus, a cryptic pathogen that originated via allodiploid hybridization. Notably, all A. latus isolates were misidentified. A. latus hybrids likely originated via a single hybridization event during the Miocene and harbor substantial genetic diversity. Transcriptome profiling of a clinical isolate revealed that both parental subgenomes are actively expressed and respond to environmental stimuli. Characterizing infection-relevant traits-such as drug resistance and growth under oxidative stress-revealed distinct phenotypic profiles among A. latus hybrids compared to parental and closely related species. Moreover, we identified four features that could aid A. latus taxonomic identification. Together, these findings deepen our understanding of the origin of cryptic pathogens.

Indexed as

AspergillusCOVID-19Genetic VariationGenome, FungalPhylogenyEvolution, MolecularGene Expression ProfilingHumansHybridization, GeneticPhenotypeSARS-CoV-2

Identifiers

PMID39333551
PMCPMC11436853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.